Financhill
Buy
60

HQY Quote, Financials, Valuation and Earnings

Last price:
$84.35
Seasonality move :
9.56%
Day range:
$82.45 - $87.35
52-week range:
$65.01 - $115.59
Dividend yield:
0%
P/E ratio:
78.78x
P/S ratio:
6.35x
P/B ratio:
3.51x
Volume:
559.5K
Avg. volume:
1.4M
1-year change:
8.64%
Market cap:
$7.4B
Revenue:
$1.2B
EPS (TTM):
$1.09

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HQY
HealthEquity
$305.8M $0.72 12.21% 147.57% $110.93
HSTM
HealthStream
$74.9M $0.17 2.98% -- $35.00
SDGR
Schrodinger
$54.6M -$0.81 49.19% -6.58% $31.78
SLP
Simulations Plus
$21.9M $0.26 23.35% 85.71% $46.60
VEEV
Veeva Systems
$699.4M $1.58 11.93% 76.63% $261.98
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HQY
HealthEquity
$85.87 $110.93 $7.4B 78.78x $0.00 0% 6.35x
HSTM
HealthStream
$33.28 $35.00 $1B 50.42x $0.03 0.35% 3.49x
SDGR
Schrodinger
$26.45 $31.78 $1.9B -- $0.00 0% 9.26x
SLP
Simulations Plus
$35.50 $46.60 $713.9M 101.43x $0.06 0.68% 9.17x
VEEV
Veeva Systems
$227.54 $261.98 $37B 52.55x $0.00 0% 13.68x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HQY
HealthEquity
33.31% 2.209 11.05% 2.65x
HSTM
HealthStream
-- 1.077 -- 1.15x
SDGR
Schrodinger
-- 2.153 -- 3.17x
SLP
Simulations Plus
-- 1.840 -- 3.54x
VEEV
Veeva Systems
-- 0.930 -- 4.44x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HQY
HealthEquity
$189M $44.3M 3.11% 4.59% 14.5% $62.2M
HSTM
HealthStream
$49.1M $4.7M 5.72% 5.72% 6.32% $4.3M
SDGR
Schrodinger
$64.1M -$20.7M -38.87% -38.87% -23.45% -$32M
SLP
Simulations Plus
$13.1M $2.7M 3.97% 3.97% 12.09% $4.7M
VEEV
Veeva Systems
$539.9M $188.4M 13.71% 13.71% 26.14% $69.5M

HealthEquity vs. Competitors

  • Which has Higher Returns HQY or HSTM?

    HealthStream has a net margin of 8.46% compared to HealthEquity's net margin of 6.59%. HealthEquity's return on equity of 4.59% beat HealthStream's return on equity of 5.72%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    HSTM
    HealthStream
    66.17% $0.16 $359.4M
  • What do Analysts Say About HQY or HSTM?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 29.18%. On the other hand HealthStream has an analysts' consensus of $35.00 which suggests that it could grow by 5.17%. Given that HealthEquity has higher upside potential than HealthStream, analysts believe HealthEquity is more attractive than HealthStream.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    HSTM
    HealthStream
    2 4 0
  • Is HQY or HSTM More Risky?

    HealthEquity has a beta of 0.487, which suggesting that the stock is 51.287% less volatile than S&P 500. In comparison HealthStream has a beta of 0.417, suggesting its less volatile than the S&P 500 by 58.337%.

  • Which is a Better Dividend Stock HQY or HSTM?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthStream offers a yield of 0.35% to investors and pays a quarterly dividend of $0.03 per share. HealthEquity pays -- of its earnings as a dividend. HealthStream pays out 17.01% of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or HSTM?

    HealthEquity quarterly revenues are $311.8M, which are larger than HealthStream quarterly revenues of $74.2M. HealthEquity's net income of $26.4M is higher than HealthStream's net income of $4.9M. Notably, HealthEquity's price-to-earnings ratio is 78.78x while HealthStream's PE ratio is 50.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 6.35x versus 3.49x for HealthStream. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    6.35x 78.78x $311.8M $26.4M
    HSTM
    HealthStream
    3.49x 50.42x $74.2M $4.9M
  • Which has Higher Returns HQY or SDGR?

    Schrodinger has a net margin of 8.46% compared to HealthEquity's net margin of -45.54%. HealthEquity's return on equity of 4.59% beat Schrodinger's return on equity of -38.87%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    SDGR
    Schrodinger
    72.61% -$0.55 $421.4M
  • What do Analysts Say About HQY or SDGR?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 29.18%. On the other hand Schrodinger has an analysts' consensus of $31.78 which suggests that it could grow by 20.14%. Given that HealthEquity has higher upside potential than Schrodinger, analysts believe HealthEquity is more attractive than Schrodinger.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    SDGR
    Schrodinger
    6 2 0
  • Is HQY or SDGR More Risky?

    HealthEquity has a beta of 0.487, which suggesting that the stock is 51.287% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.773, suggesting its more volatile than the S&P 500 by 77.334%.

  • Which is a Better Dividend Stock HQY or SDGR?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity pays -- of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or SDGR?

    HealthEquity quarterly revenues are $311.8M, which are larger than Schrodinger quarterly revenues of $88.3M. HealthEquity's net income of $26.4M is higher than Schrodinger's net income of -$40.2M. Notably, HealthEquity's price-to-earnings ratio is 78.78x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 6.35x versus 9.26x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    6.35x 78.78x $311.8M $26.4M
    SDGR
    Schrodinger
    9.26x -- $88.3M -$40.2M
  • Which has Higher Returns HQY or SLP?

    Simulations Plus has a net margin of 8.46% compared to HealthEquity's net margin of 13.7%. HealthEquity's return on equity of 4.59% beat Simulations Plus's return on equity of 3.97%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    SLP
    Simulations Plus
    58.52% $0.15 $189.5M
  • What do Analysts Say About HQY or SLP?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 29.18%. On the other hand Simulations Plus has an analysts' consensus of $46.60 which suggests that it could grow by 31.27%. Given that Simulations Plus has higher upside potential than HealthEquity, analysts believe Simulations Plus is more attractive than HealthEquity.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    SLP
    Simulations Plus
    6 1 0
  • Is HQY or SLP More Risky?

    HealthEquity has a beta of 0.487, which suggesting that the stock is 51.287% less volatile than S&P 500. In comparison Simulations Plus has a beta of 1.130, suggesting its more volatile than the S&P 500 by 13.009%.

  • Which is a Better Dividend Stock HQY or SLP?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.68% to investors and pays a quarterly dividend of $0.06 per share. HealthEquity pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or SLP?

    HealthEquity quarterly revenues are $311.8M, which are larger than Simulations Plus quarterly revenues of $22.4M. HealthEquity's net income of $26.4M is higher than Simulations Plus's net income of $3.1M. Notably, HealthEquity's price-to-earnings ratio is 78.78x while Simulations Plus's PE ratio is 101.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 6.35x versus 9.17x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    6.35x 78.78x $311.8M $26.4M
    SLP
    Simulations Plus
    9.17x 101.43x $22.4M $3.1M
  • Which has Higher Returns HQY or VEEV?

    Veeva Systems has a net margin of 8.46% compared to HealthEquity's net margin of 27.14%. HealthEquity's return on equity of 4.59% beat Veeva Systems's return on equity of 13.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    VEEV
    Veeva Systems
    74.89% $1.18 $5.8B
  • What do Analysts Say About HQY or VEEV?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 29.18%. On the other hand Veeva Systems has an analysts' consensus of $261.98 which suggests that it could grow by 15.13%. Given that HealthEquity has higher upside potential than Veeva Systems, analysts believe HealthEquity is more attractive than Veeva Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    VEEV
    Veeva Systems
    13 9 1
  • Is HQY or VEEV More Risky?

    HealthEquity has a beta of 0.487, which suggesting that the stock is 51.287% less volatile than S&P 500. In comparison Veeva Systems has a beta of 1.049, suggesting its more volatile than the S&P 500 by 4.881%.

  • Which is a Better Dividend Stock HQY or VEEV?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity pays -- of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or VEEV?

    HealthEquity quarterly revenues are $311.8M, which are smaller than Veeva Systems quarterly revenues of $720.9M. HealthEquity's net income of $26.4M is lower than Veeva Systems's net income of $195.6M. Notably, HealthEquity's price-to-earnings ratio is 78.78x while Veeva Systems's PE ratio is 52.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 6.35x versus 13.68x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    6.35x 78.78x $311.8M $26.4M
    VEEV
    Veeva Systems
    13.68x 52.55x $720.9M $195.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Too Late to Buy Gold?
Is it Too Late to Buy Gold?

Amid deep uncertainties about the future of the US economy,…

Is NextEra Energy a Stock to Hold Forever?
Is NextEra Energy a Stock to Hold Forever?

NextEra Energy (NYSE:NEE) share price sold off hard in recent…

Why Did Bill Ackman Buy Alphabet Stock?
Why Did Bill Ackman Buy Alphabet Stock?

Bill Ackman has become famous in the investing world for…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Sell
27
SAIA alert for Apr 28

Saia [SAIA] is down 3.49% over the past day.

Sell
36
APPF alert for Apr 29

AppFolio [APPF] is up 5.02% over the past day.

Sell
15
KNSL alert for Apr 28

Kinsale Capital Group [KNSL] is up 0.99% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock